IMMUNIC (IMUX) director receives 25,370 stock options at $14.80 strike price
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
IMMUNIC, INC. director Joerg Neermann received a grant of stock options covering 25,370 shares of common stock. The options have an exercise price of $14.80 per share and expire on July 5, 2036. They vest in monthly increments over one year from the grant date.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Neermann Joerg
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option | 25,370 | $0.00 | -- |
Holdings After Transaction:
Stock Option — 25,370 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Options granted: 25,370 options
Exercise price: $14.80 per share
Expiration date: July 5, 2036
+2 more
5 metrics
Options granted
25,370 options
Stock option grant to director on July 5, 2026
Exercise price
$14.80 per share
Strike price for IMMUNIC common stock under the option
Expiration date
July 5, 2036
Option term end date
Underlying shares
25,370 shares
IMMUNIC common stock underlying the option grant
Vesting schedule
Monthly over one year
From the grant date per footnote
Key Terms
Stock Option, exercise price, expiration date, Grant, award, or other acquisition, +1 more
5 terms
Stock Option financial
"security_title: "Stock Option" with underlying IMMUNIC common stock"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
exercise price financial
"conversion_or_exercise_price: "14.8000" per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: "2036-07-05T00:00:00.000Z" for the option grant"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
Grant, award, or other acquisition financial
"transaction_code_description: "Grant, award, or other acquisition""
vests in monthly increments financial
"The option vests in monthly increments over a period of one year"
FAQ
What insider transaction did IMMUNIC (IMUX) report for Joerg Neermann?
IMMUNIC reported that director Joerg Neermann received a grant of 25,370 stock options. These options give him the right to buy IMMUNIC common shares at a fixed exercise price, aligning part of his compensation with the company’s future stock performance.
What is the exercise price of Joerg Neermann’s new IMMUNIC (IMUX) stock options?
The granted stock options have an exercise price of $14.80 per share. This means Neermann can buy IMMUNIC common stock at $14.80, regardless of future market price, once the options vest and before they expire on July 5, 2036.
When do Joerg Neermann’s IMMUNIC (IMUX) stock options vest?
The stock options vest in monthly increments over one year from the grant date. This structure gradually delivers exercisable options each month, encouraging continued board service and tying Neermann’s potential equity benefits to his ongoing role with IMMUNIC.
What is the expiration date of Joerg Neermann’s IMMUNIC (IMUX) stock options?
The options expire on July 5, 2036. Neermann must exercise any vested options before that expiration date to acquire IMMUNIC common shares; unexercised options after that date will lapse and no longer be exercisable.
Is Joerg Neermann’s IMMUNIC (IMUX) option grant an open-market purchase or sale?
The filing classifies this as a grant or award acquisition, not an open-market trade. Neermann received the options from IMMUNIC as compensation, with no reported cash purchase or sale of shares on the market associated with this grant.